POMDOCTOR LIMITED Regains Compliance with Nasdaq Bid Price Requirement
PomDoctor Limited announced that it has regained compliance with the Nasdaq minimum bid price requirement, leading to the cancellation of a previously scheduled hearing.
Stocks · News reference
The company has been targeted in an aggressive two-year-old campaign to delist suspicious Chinese companies from Wall Street image credit: Bamboo Works Key Takeaways: Here today, gone tomorrow. That
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
PomDoctor Limited announced that it has regained compliance with the Nasdaq minimum bid price requirement, leading to the cancellation of a previously scheduled hearing.
Pomdoctor Limited announced it received two letters from Nasdaq regarding deficiencies in meeting continued listing requirements for the Nasdaq Global Market.
Gainers CareDx (NASDAQ:CDNA) shares rose 22.2% to $87.42 during Friday's regular session. The company's market cap stands at $3.7 billion. As per the press release, Q3 earnings came out yesterday. Jin Medical
The termination was previously approved by the board of directors of Pomdoctor on September 3, 2026 and approved by the Company's shareholders on a non-binding advisory basis at the extraordinary general meeting of